Overview
Ryo Komorizono practices practicing medicine in Tokyo, Japan.
His clinical expertise encompasses Cysticercosis, Severe Acute Respiratory Syndrome (SARS), and Schistosomiasis.
He is actively involved in clinical research, co-authoring 19 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ryo Komorizono
Is Ryo Komorizono a top-rated expert for Cysticercosis?
MediFind is an objective health platform that identifies experts based on real-world data. Ryo Komorizono is classified as an Experienced expert for Cysticercosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ryo Komorizono participate in research or clinical trials?
Yes. Ryo Komorizono has published 19 articles and abstracts on conditions like Cysticercosis. You can view a list of Ryo Komorizono's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- CysticercosisMr. Komorizono isExperienced. Learn about Cysticercosis.
- SchistosomiasisMr. Komorizono isExperienced. Learn about Schistosomiasis.
- Severe Acute Respiratory Syndrome (SARS)Mr. Komorizono isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).